[
    {
        "dcterms:creator": [
            "B. Lia",
            "M. Anthimopoulos"
        ],
        "dcterms:description": "The datasets were from a pilot prospective randomized controlled crossover study of GoCARB, involving 20 adults with Type 1 Diabetes. The CGM measurements were taken every 5 minutes, resulting in 26 sub-datasets with a minimum length of 1500 measurements.",
        "dcterms:title": "Datasets from real patients",
        "dcterms:issued": "2017",
        "dcterms:language": "",
        "dcterms:identifier": "",
        "dcat:theme": [
            "Diabetes",
            "Blood Glucose Monitoring"
        ],
        "dcat:keyword": [
            "Type 1 Diabetes",
            "Continuous Glucose Monitoring",
            "CGM Data",
            "Blood Glucose Prediction"
        ],
        "dcat:landingPage": "",
        "dcterms:hasVersion": "",
        "dcterms:format": "Data",
        "mls:task": [
            "Blood Glucose Prediction"
        ]
    },
    {
        "dcterms:creator": [
            "M. Anthimopoulos"
        ],
        "dcterms:description": "The FDA-accepted UVa/Padova T1D Simulator was used to conduct in silico clinical trials for 11 virtual adult subjects, generating glucose measurements for training and testing the prediction model.",
        "dcterms:title": "FDA-accepted UVa/Padova T1D Simulator",
        "dcterms:issued": "2015",
        "dcterms:language": "",
        "dcterms:identifier": "",
        "dcat:theme": [
            "Diabetes",
            "Simulation"
        ],
        "dcat:keyword": [
            "In Silico Trials",
            "Type 1 Diabetes",
            "Glucose Simulation",
            "Clinical Trials"
        ],
        "dcat:landingPage": "",
        "dcterms:hasVersion": "",
        "dcterms:format": "Data",
        "mls:task": [
            "Blood Glucose Prediction"
        ]
    }
]